Cryo-Cell International, Inc. (CCEL.OB) Partners with Monash University to Develop Revolutionary Autoimmune Disease Therapies
Cryo-Cell International, www.cryo-cell.com, an undisputed leader in stem cell technology with some 215k clients globally, CCEL today reported a collaboration agreement with Australia’s Monash University to use the proprietary menstrual stem cell technology (MenScs) behind its Célle service to create therapies for MS (multiple sclerosis) and other autoimmune diseases. When working with bone marrow stem cells (which are routinely isolated from patients for various disease treatments), Dr. James Chan and colleagues at the Monash Centre of Inflammatory Diseases, MNHS (Faculty of Medicine Nursing and Health Sciences) developed a method whereby isolation, genetic manipulation and subsequent transplantation of these cells shows…